Skip to main content
Journal cover image

TASQUINIMOD MECHANISM OF ACTION BIOMARKERS: CORRELATION WITH PFS AND SURVIVAL IN MEN WITH METASTATIC CASTRATE RESISTANT PROSTATE CANCER TREATED IN A RANDOMIZED PHASE 2 TRIAL

Publication ,  Conference
Carducci, M; Armstrong, A; Haggman, M; Stadler, WM; Gingrich, JR; Assikis, V; Forsberg, G; Olsson, A; Nordle, O; Pili, R
Published in: ANNALS OF ONCOLOGY
September 1, 2012

Duke Scholars

Published In

ANNALS OF ONCOLOGY

ISSN

0923-7534

Publication Date

September 1, 2012

Volume

23

Start / End Page

303 / 303

Location

Vienna, AUSTRIA

Publisher

OXFORD UNIV PRESS

Conference Name

37th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Carducci, M., Armstrong, A., Haggman, M., Stadler, W. M., Gingrich, J. R., Assikis, V., … Pili, R. (2012). TASQUINIMOD MECHANISM OF ACTION BIOMARKERS: CORRELATION WITH PFS AND SURVIVAL IN MEN WITH METASTATIC CASTRATE RESISTANT PROSTATE CANCER TREATED IN A RANDOMIZED PHASE 2 TRIAL. In ANNALS OF ONCOLOGY (Vol. 23, pp. 303–303). Vienna, AUSTRIA: OXFORD UNIV PRESS.
Carducci, M., A. Armstrong, M. Haggman, W. M. Stadler, J. R. Gingrich, V. Assikis, G. Forsberg, A. Olsson, O. Nordle, and R. Pili. “TASQUINIMOD MECHANISM OF ACTION BIOMARKERS: CORRELATION WITH PFS AND SURVIVAL IN MEN WITH METASTATIC CASTRATE RESISTANT PROSTATE CANCER TREATED IN A RANDOMIZED PHASE 2 TRIAL.” In ANNALS OF ONCOLOGY, 23:303–303. OXFORD UNIV PRESS, 2012.
Carducci M, Armstrong A, Haggman M, Stadler WM, Gingrich JR, Assikis V, et al. TASQUINIMOD MECHANISM OF ACTION BIOMARKERS: CORRELATION WITH PFS AND SURVIVAL IN MEN WITH METASTATIC CASTRATE RESISTANT PROSTATE CANCER TREATED IN A RANDOMIZED PHASE 2 TRIAL. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2012. p. 303–303.
Carducci M, Armstrong A, Haggman M, Stadler WM, Gingrich JR, Assikis V, Forsberg G, Olsson A, Nordle O, Pili R. TASQUINIMOD MECHANISM OF ACTION BIOMARKERS: CORRELATION WITH PFS AND SURVIVAL IN MEN WITH METASTATIC CASTRATE RESISTANT PROSTATE CANCER TREATED IN A RANDOMIZED PHASE 2 TRIAL. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2012. p. 303–303.
Journal cover image

Published In

ANNALS OF ONCOLOGY

ISSN

0923-7534

Publication Date

September 1, 2012

Volume

23

Start / End Page

303 / 303

Location

Vienna, AUSTRIA

Publisher

OXFORD UNIV PRESS

Conference Name

37th Congress of the European-Society-for-Medical-Oncology (ESMO)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
  • 1112 Oncology and Carcinogenesis